Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25656474 | 1.00 | MAPT (0.36) | MAPTPKMALDH1A1GAAEGFR | |
| SCHEMBL24960484 | 0.86 | MAPT (0.36) | MAPTPKMALDH1A1GAAEGFR | |
| SCHEMBL21935906 | 0.84 | MAPT (0.36) | MAPTPKMALDH1A1GAAEGFR | |
| SCHEMBL24960478 | 0.84 | MAPT (0.36) | MAPTPKMALDH1A1GAAEGFR | |
| SCHEMBL21173225 | 0.84 | USP8 (0.40) | MAPTPKMALDH1A1GAAEGFR | |
| SCHEMBL25656471 | 0.84 | LCK (0.36) | MAPTPKMALDH1A1GAAEGFR | |
| SCHEMBL21173224 | 0.84 | LCK (0.36) | MAPTPKMALDH1A1GAAEGFR | |
| SCHEMBL25612614 | 0.84 | USP8 (0.40) | MAPTPKMALDH1A1GAAEGFR | |
| SCHEMBL24960488 | 0.84 | ALDH1A1 (0.33) | MAPTPKMALDH1A1GAAEGFR | |
| SCHEMBL20821300 | 0.84 | ALDH1A1 (0.33) | MAPTPKMALDH1A1GAAEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022033993-A1 | PHOTOACTIVE MATERIAL | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2022-02-17 | — | — | WO | disclosed |
| WO-2021156605-A1 | PHOTOACTIVE MATERIAL | SUMITOMO CHEMICAL CO., LTD (JP) | 2021-08-12 | — | — | WO | disclosed |
| US-20200251661-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-08-06 | — | — | US | disclosed |
| WO-2019137354-A1 | THIOPHENE-BASED FUSED AROMATIC SYSTEMS | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2019-07-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200251661-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | ODC1, OR10J3, CYP1A1 | MAPT 3296/4885PKM 2476/4885ALDH1A1 82/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.